DXB
DIMERIX LTD ORDINARYDimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
DXB
DXB
DIMERIX LTD ORDINARY
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 22 July | — | — |
| 21 July | — | — |
| 20 July | — | — |
| 17 July | 0.22% | — |
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | — | — |
| 10 July | — | — |
| 9 July | — | — |
| 8 July | — | — |
| 7 July | — | — |
Dimerix LTD (DXB) Short Interest Summary
Dimerix LTD (DXB) currently has 0.22% of its shares sold short (1.3 million shares, worth approximately $332K), based on ASIC short position data reported on 17 July 2026 (T+4 reporting lag). That makes DXB the #406 most shorted stock on the ASX most shorted list. Short interest in DXB is up 0.18% over the past week and up 0.22% over the past month. DXB is part of the Health Care sector on the ASX.
Recent DXB Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 17 July 2026 | 0.22% | 1.3M | $0.24 |
| 23 June 2026 | 0.02% | 0.1M | $0.20 |
| 22 June 2026 | 0.15% | 0.9M | $0.22 |
| 19 June 2026 | 0.03% | 0.2M | $0.22 |
| 18 June 2026 | 0.03% | 0.2M | $0.21 |
| 17 June 2026 | 0.04% | 0.2M | $0.19 |
| 16 June 2026 | 0.04% | 0.2M | $0.20 |
| 11 June 2026 | 0.00% | 0.0M | $0.17 |
| 10 June 2026 | 0.00% | 0.0M | $0.17 |
| 9 June 2026 | 0.01% | 0.0M | $0.17 |
DXB Short Selling — Frequently Asked Questions
What is Dimerix LTD (DXB)'s current short interest?
Dimerix LTD (DXB) currently has a short interest of 0.22% of total shares outstanding. This means 0.22% of DXB's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is DXB heavily shorted on the ASX?
DXB has a relatively low short interest of 0.22%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for DXB investors?
Short interest in DXB shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.22%, DXB's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this DXB short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for DXB.